Delivery Order SPE2DB25D3110-SPE2DB25FTEAY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count) with a ceiling value of $5,275.63. This competitive, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dapagliflozin 10 mg tablets in a quantity of 30-unit packages, with a ceiling value of $5,581.69. This contract, awarded on August 7, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and carries no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,100.65 to AmerisourceBergen Drug Corp for Dapagliflozin 10 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitive award, which utilized no set-aside designation, was executed under a firm fixed-price contract structure with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The dapagliflozin delivery supports the federal...
- The Defense Logistics Agency awarded a delivery order valued at $6,756.65 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen will perform this delivery from its corporate headquarters in Conshohocken, Pennsylvania, where the company maintains significant pharmaceutical distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,376.58 to AmerisourceBergen Drug Corp for the supply of Dapagliflozin 10 mg tablets (30-count packaging) on August 4, 2025, with completion targeted for August 5, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dapagliflozin 10 mg tablets (30-count package) under a firm fixed-price contract valued at $1,722.16. This is a non-set-aside competitive award with an ultimate completion date of August 4, 2025, with performance to take place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a ceiling value of $28,970.38. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and represents a component of the company's broader pharmaceutical supply relationship with the federal government. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Dapagliflozin 10 mg tablets in quantities of 30 units, with a ceiling value of $5,781.60. This contract represents a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and was competitively awarded with no set-aside designation. The award is classified as a child contract, indicating it derives from a larger contract vehicle. AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $11,731.88 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- The Defense Logistics Agency awarded a delivery order valued at $32,773.46 to AmerisourceBergen Drug Corp for Dapagliflozin 10 mg tablets (30-count packaging). The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, and employed firm fixed-price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order represents a competitive award...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTEAYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dapagliflozin 10 mg tablets (30-count packages) with a ceiling value of $4,540.43. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, utilizing no set-aside designation. The contract represents a competitive award under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Dapagliflozin is a commonly prescribed diabetes medication, consistent with the company's extensive portfolio of therapeutic medications delivered through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 8/8/25 |